ArriVent Biopharma

ArriVent BioPharma (NASDAQ: AVBP) is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines for the treatment of cancer. Its lead candidate is firmonertinib, an EGFR inhibitor being studied across non-small cell lung cancer indications, and its pipeline includes next-generation antibody drug conjugates such as ARR-002. The company operates by identifying novel oncology programs, in-licensing drug candidates through partnerships, and designing regulatory-compliant clinical development strategies. It was surfaced as a portfolio company of HongShan and added to the API Evangelist network; as a traditional pharmaceutical developer it publishes no public API, developer portal, or technical integration surface.

ArriVent Biopharma is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Biopharmaceutical, Oncology, and Pharmaceuticals.

🌐 Visit website 📡 Source on GitHub

7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyHealthcareBiopharmaceuticalOncologyPharmaceuticalsClinical TrialsDrug Development

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 7.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/arrivent-biopharma: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: arrivent-biopharma
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/arrivent-biopharma.png
name: ArriVent Biopharma
description: 'ArriVent BioPharma (NASDAQ: AVBP) is a clinical-stage biopharmaceutical company dedicated to the identification,
  development, and commercialization of differentiated medicines for the treatment of cancer. Its lead candidate is firmonertinib,
  an EGFR inhibitor being studied across non-small cell lung cancer indications, and its pipeline includes next-generation
  antibody drug conjugates such as ARR-002. The company operates by identifying novel oncology programs, in-licensing drug
  candidates through partnerships, and designing regulatory-compliant clinical development strategies. It was surfaced as
  a portfolio company of HongShan and added to the API Evangelist network; as a traditional pharmaceutical developer it publishes
  no public API, developer portal, or technical integration surface.'
url: https://raw.githubusercontent.com/api-evangelist/arrivent-biopharma/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- hongshan
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Healthcare
- Biopharmaceutical
- Oncology
- Pharmaceuticals
- Clinical Trials
- Drug Development
apis: []
common:
- type: DomainSecurity
  url: security/arrivent-biopharma-domain-security.yml
- type: Website
  url: https://www.arrivent.com
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence

ArriVent Biopharma

Kin Score

Security Posture 1

Arrivent Biopharma Domain Security

Resources

Access & Security 1

Company 1

Source (apis.yml)